James T. Treace has served as the chairman of our board of directors since June 2014. Mr. Treace has served as the Founder and President of J&A Group, LLC, a privately funded medical device investment and consulting company, since October 2000. Before that, from November 1999 to October 2000, Mr. Treace served as President of Medtronic Xomed, a subsidiary of Medtronic plc (NYSE: MDT). From April 1996 to November 1999, Mr. Treace served as Chief Executive Officer, President and Chairman of the board of directors of Xomed Surgical Products, Inc. (NASDAQ: XOMD), until it was acquired by Medtronic plc. From July 1993 to April 1996, Mr. Treace co-founded and served as the Chief Executive Officer and Chairman of the Board at TreBay Medical Corp., an orthopaedic and microsurgical device company. From September 1981 to July 1990, he served as President and Chief Executive Officer of Concept, Inc. (NASDAQ: CCPT), now known as Conmed Linvatec (NYSE: CNMD) and from June 1966 to September 1981 as Executive Vice President of Richards Medical, now known as Smith & Nephew (NYSE: SNN). Mr. Treace previously served as Chairman of the Boards of Kyphon, Inc. (NASDAQ: KYPH), now part of Medtronic plc, Wright Medical, acquired by Stryker Corporation (NYSE: SYK) in November 2020, American Medical Systems, Inc. (NASDAQ: AMMD), now part of Endo Pharmaceuticals (NASDAQ: ENDP), and Keystone Dental, Inc., a privately-held dental implant company.
What is James T. Treace's net worth?
The estimated net worth of James T. Treace is at least $10.77 million as of April 28th, 2023. Mr. Treace owns 871,441 shares of Treace Medical Concepts stock worth more than $10,771,011 as of March 28th. This net worth approximation does not reflect any other investments that Mr. Treace may own. Learn More about James T. Treace's net worth.
How do I contact James T. Treace?
Has James T. Treace been buying or selling shares of Treace Medical Concepts?
James T. Treace has not been actively trading shares of Treace Medical Concepts during the last quarter. Most recently, James T. Treace sold 10,000 shares of the business's stock in a transaction on Monday, May 1st. The shares were sold at an average price of $25.24, for a transaction totalling $252,400.00. Following the completion of the sale, the director now directly owns 861,441 shares of the company's stock, valued at $21,742,770.84. Learn More on James T. Treace's trading history.
Who are Treace Medical Concepts' active insiders?
Are insiders buying or selling shares of Treace Medical Concepts?
During the last twelve months, insiders at the sold shares 11 times. They sold a total of 1,300,798 shares worth more than $34,301,778.93. The most recent insider tranaction occured on June, 5th when Director F Barry Bays sold 1,042,318 shares worth more than $27,631,850.18. Insiders at Treace Medical Concepts own 28.7% of the company.
Learn More about insider trades at Treace Medical Concepts. Information on this page was last updated on 6/5/2023.